{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-361275","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2021-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.245003+00:00","generated_at":"2026-06-28T00:12:37.635159+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ALX Oncology enters $150M at-the-market stock offering agreement","bullets":["Entered Sales Agreement with Cantor Fitzgerald and Credit Suisse for ATM offering of up to $150M in common stock.","Sales may be made at-the-market on Nasdaq or in negotiated transactions; company sets parameters per placement notice.","Sales Agents receive 3.0% commission per share sold; company not obligated to sell any shares.","Offering made under existing S-3 shelf registration (filed August 2021); prospectus supplement filed December 17, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-361275","json":"https://secwatch.observer/filing/0001193125-21-361275.json","markdown":"https://secwatch.observer/filing/0001193125-21-361275.md","text":"https://secwatch.observer/filing/0001193125-21-361275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312521361275/0001193125-21-361275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312521361275/d227281d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:12:37.635159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}